BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 24692589)

  • 1. The decision on the "optimal" human pluripotent stem cell.
    Rosner M; Schipany K; Hengstschläger M
    Stem Cells Transl Med; 2014 May; 3(5):553-9. PubMed ID: 24692589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient Cardiac Differentiation of Human Amniotic Fluid-Derived Stem Cells into Induced Pluripotent Stem Cells and Their Potential Immune Privilege.
    Fang YH; Wang SPH; Gao ZH; Wu SN; Chang HY; Yang PJ; Liu PY; Liu YW
    Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32235313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ES, iPS, MSC, and AFS cells. Stem cells exploitation for Pediatric Surgery: current research and perspective.
    Pozzobon M; Ghionzoli M; De Coppi P
    Pediatr Surg Int; 2010 Jan; 26(1):3-10. PubMed ID: 19727766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stem cells. Versatile stem cells without the ethical baggage?
    Holden C
    Science; 2007 Jan; 315(5809):170. PubMed ID: 17218496
    [No Abstract]   [Full Text] [Related]  

  • 5. Nuclear reprogramming and induced pluripotent stem cells: a review for surgeons.
    Qi SD; Smith PD; Choong PF
    ANZ J Surg; 2014 Jun; 84(6):E1-11. PubMed ID: 23035845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative analysis of the retinal potential of embryonic stem cells and amniotic fluid-derived stem cells.
    Decembrini S; Cananzi M; Gualdoni S; Battersby A; Allen N; Pearson RA; Ali RR; De Coppi P; Sowden JC
    Stem Cells Dev; 2011 May; 20(5):851-63. PubMed ID: 20939691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A plethora of human pluripotent stem cells.
    Gao L; Thilakavathy K; Nordin N
    Cell Biol Int; 2013 Sep; 37(9):875-87. PubMed ID: 23619972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "Mouse Clone Model" for evaluating the immunogenicity and tumorigenicity of pluripotent stem cells.
    Zhang G; Zhang Y
    Stem Cell Res Ther; 2015 Dec; 6():255. PubMed ID: 26687081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The bioethics of stem cell research and therapy.
    Hyun I
    J Clin Invest; 2010 Jan; 120(1):71-5. PubMed ID: 20051638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear reprogramming and induced pluripotent stem cells: a review for surgeons.
    Qi SD; Smith PD; Choong PF
    ANZ J Surg; 2014 Jun; 84(6):417-23. PubMed ID: 24894037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concise review: stem cells for the treatment of cerebellar-related disorders.
    Erceg S; Moreno-Manzano V; Garita-Hernandez M; Stojkovic M; Bhattacharya SS
    Stem Cells; 2011 Apr; 29(4):564-9. PubMed ID: 21319272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurogenic differentiation of amniotic fluid stem cells.
    Rosner M; Mikula M; Preitschopf A; Feichtinger M; Schipany K; Hengstschläger M
    Amino Acids; 2012 May; 42(5):1591-6. PubMed ID: 21573873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential antitumor therapeutic strategies of human amniotic membrane and amniotic fluid-derived stem cells.
    Kang NH; Hwang KA; Kim SU; Kim YB; Hyun SH; Jeung EB; Choi KC
    Cancer Gene Ther; 2012 Aug; 19(8):517-22. PubMed ID: 22653384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient-specific pluripotent stem cells: promises and challenges.
    Müller R; Lengerke C
    Nat Rev Endocrinol; 2009 Apr; 5(4):195-203. PubMed ID: 19352317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct Reprogramming of Human Amniotic Fluid Stem Cells by OCT4 and Application in Repairing of Cerebral Ischemia Damage.
    Qin M; Chen R; Li H; Liang H; Xue Q; Li F; Chen Y; Zhang X
    Int J Biol Sci; 2016; 12(5):558-68. PubMed ID: 27019637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do we still need human embryonic stem cells for stem cell-based therapies? Epistemic and ethical aspects.
    Hug K; Hermerén G
    Stem Cell Rev Rep; 2011 Nov; 7(4):761-74. PubMed ID: 21461713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induced pluripotent stem (iPS) cells from human fetal stem cells (hFSCs).
    Spinelli V; Guillot PV; De Coppi P
    Organogenesis; 2013; 9(2):101-10. PubMed ID: 23823661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Embryonic stem cells or induced pluripotent stem cells? A DNA integrity perspective.
    Bai Q; Desprat R; Klein B; Lemaître JM; De Vos J
    Curr Gene Ther; 2013 Apr; 13(2):93-8. PubMed ID: 23317057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paracrine Effects of the Pluripotent Stem Cell-Derived Cardiac Myocytes Salvage the Injured Myocardium.
    Tachibana A; Santoso MR; Mahmoudi M; Shukla P; Wang L; Bennett M; Goldstone AB; Wang M; Fukushi M; Ebert AD; Woo YJ; Rulifson E; Yang PC
    Circ Res; 2017 Sep; 121(6):e22-e36. PubMed ID: 28743804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stem cells in amniotic fluid as new tools to study human genetic diseases.
    Siegel N; Rosner M; Hanneder M; Valli A; Hengstschläger M
    Stem Cell Rev; 2007 Dec; 3(4):256-64. PubMed ID: 17955390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.